Please enable JavaScript to continue using this application.

Compare $AVXL vs $SPRB | Chartloom

Compare

$AVXL vs $SPRB

Anavex Life Sciences Corp · Spruce Biosciences, Inc

AVXL

Anavex Life Sciences Corp

SPRB

Spruce Biosciences, Inc

Compare $AVXL vs $SPRB

Comparing Anavex Life Sciences Corp and Spruce Biosciences, Inc

AVXLAnavex Life Sciences Corp

SPRBSpruce Biosciences, Inc

AVXLAnavex Life Sciences Corp

Market cap

$138M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-59.5%

52W performance

-84.9%

FCF yield

-21.2%

SPRBSpruce Biosciences, Inc

Market cap

$121M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-51.4%

52W performance

-72.5%

FCF yield

-35.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AVXL

SPRB

Detailed metrics comparison

AVXL

Anavex Life Sciences Corp

SPRB

Spruce Biosciences, Inc

Market Cap

AVXL$138M

SPRB$121M

Enterprise Value

AVXL$20M

SPRB$32M

Price

AVXL$1.49

SPRB$44.05

P/E Ratio

AVXLN/A

SPRBN/A

P/S Ratio

AVXL0.00x

SPRB26.75x

EV/Sales

AVXL0.00x

SPRB8.59x

EV/EBITDA

AVXL0.00x

SPRB0.00x

P/B Ratio

AVXL1.50x

SPRB1.57x

P/FCF Ratio

AVXLN/A

SPRBN/A

EV/FCF

AVXL-0.67x

SPRB-0.75x

PEG Ratio

AVXLN/A

SPRBN/A

Forward P/E (NTM)

AVXLN/A

SPRBN/A

Forward P/S (NTM)

AVXLN/A

SPRBN/A

Revenue (TTM)

AVXL$0

SPRB$0

Revenue Growth (YoY)

AVXLN/A

SPRBN/A

Forward Rev Growth

AVXL377.5%

SPRB-75.6%

Gross Margin (TTM)

AVXL0.0%

SPRB0.0%

Operating Margin (TTM)

AVXL0.0%

SPRB0.0%

EBITDA Margin (TTM)

AVXL0.0%

SPRB0.0%

Net Margin (TTM)

AVXL0.0%

SPRB0.0%

FCF Margin (TTM)

AVXLN/A

SPRBN/A

Net Income (TTM)

AVXL$-13M

SPRB$-51M

FCF (TTM)

AVXL$-29M

SPRB$-43M

EPS (TTM)

AVXL-$0.14

SPRB-$21.14

ROE (TTM)

AVXL-1143.0%

SPRB-15540.0%

ROA (TTM)

AVXL-1072.0%

SPRB-10167.0%

ROIC (TTM)

AVXL-1143.0%

SPRB-14349.0%

Cash

AVXL$118M

SPRB$96M

Debt

AVXL$0

SPRB$7M

Net Cash/Debt

AVXL$118M

SPRB$89M

Current Ratio (TTM)

AVXL15.62x

SPRB9.23x

Quick Ratio (TTM)

AVXL15.51x

SPRB8.81x

Debt/Equity (TTM)

AVXL0.00x

SPRB0.08x

Debt/Assets (TTM)

AVXL0.0%

SPRB0.0%

Interest Coverage (TTM)

AVXLN/A

SPRBN/A

Net Debt/EBITDA (TTM)

AVXL0.00x

SPRB0.00x

Beta

AVXL1.20

SPRB3.63

52W Performance

AVXL-84.9%

SPRB-72.5%

YTD Performance

AVXL-59.5%

SPRB-51.4%

% from 52W High

AVXL-85.0%

SPRB-77.9%

% from 52W Low

AVXL3.5%

SPRB9.2%

Asset Turnover (TTM)

AVXL0.00x

SPRB0.07x

FCF Yield (TTM)

AVXL-21.2%

SPRB-35.3%

Earnings Yield (TTM)

AVXL-9.4%

SPRB-42.4%

Dividend Yield (TTM)

AVXLN/A

SPRBN/A

Rule of 40

AVXL0.0

SPRB0.0

EV/GP/RG

AVXLN/A

SPRBN/A

Ticker research

View AVXL research View SPRB research

Metric	AVXL Anavex Life Sciences Corp	SPRB Spruce Biosciences, Inc
Market & Valuation
Market Cap	$138M	$121M
Enterprise Value	$20M	$32M
Price	$1.49	$44.05
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	26.75x
EV/Sales	0.00x	8.59x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-0.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	377.5%	-75.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-13M	$-51M
FCF (TTM)	$-29M	$-43M
EPS (TTM)	-$0.14	-$21.14
ROE (TTM)	-1143.0%	-15540.0%
ROA (TTM)	-1072.0%	-10167.0%
ROIC (TTM)	-1143.0%	-14349.0%
Financial Health
Cash	$118M	$96M
Debt	$0	$7M
Net Cash/Debt	$118M	$89M
Current Ratio (TTM)	15.62x	9.23x
Quick Ratio (TTM)	15.51x	8.81x
Debt/Equity (TTM)	0.00x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	3.63
52W Performance	-84.9%	-72.5%
YTD Performance	-59.5%	-51.4%
% from 52W High	-85.0%	-77.9%
% from 52W Low	3.5%	9.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	-21.2%	-35.3%
Earnings Yield (TTM)	-9.4%	-42.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AVXL research	View SPRB research

Valuation

P/S Ratio

AVXL

0.00x

SPRB

26.75x

EV/FCF

SPRB

-0.75x

AVXL

-0.67x

Growth & revenue

Forward Revenue Growth

AVXL

377.5%

SPRB

-75.6%

Profitability & performance

Gross Margin

AVXL

0.0%

SPRB

0.0%

ROE

AVXL

-1143.0%

SPRB

-15540.0%

FCF Yield %

AVXL

-21.2%

SPRB

-35.3%

52-Week Performance

SPRB

-72.5%

AVXL

-84.9%

Detailed metrics comparison

AVXL

Anavex Life Sciences Corp

SPRB

Spruce Biosciences, Inc

Market Cap

AVXL$138M

SPRB$121M

Enterprise Value

AVXL$20M

SPRB$32M

Price

AVXL$1.49

SPRB$44.05

P/E Ratio

AVXLN/A

SPRBN/A

P/S Ratio

AVXL0.00x

SPRB26.75x

EV/Sales

AVXL0.00x

SPRB8.59x

EV/EBITDA

AVXL0.00x

SPRB0.00x

P/B Ratio

AVXL1.50x

SPRB1.57x

P/FCF Ratio

AVXLN/A

SPRBN/A

EV/FCF

AVXL-0.67x

SPRB-0.75x

PEG Ratio

AVXLN/A

SPRBN/A

Forward P/E (NTM)

AVXLN/A

SPRBN/A

Forward P/S (NTM)

AVXLN/A

SPRBN/A

Revenue (TTM)

AVXL$0

SPRB$0

Revenue Growth (YoY)

AVXLN/A

SPRBN/A

Forward Rev Growth

AVXL377.5%

SPRB-75.6%

Gross Margin (TTM)

AVXL0.0%

SPRB0.0%

Operating Margin (TTM)

AVXL0.0%

SPRB0.0%

EBITDA Margin (TTM)

AVXL0.0%

SPRB0.0%

Net Margin (TTM)

AVXL0.0%

SPRB0.0%

FCF Margin (TTM)

AVXLN/A

SPRBN/A

Net Income (TTM)

AVXL$-13M

SPRB$-51M

FCF (TTM)

AVXL$-29M

SPRB$-43M

EPS (TTM)

AVXL-$0.14

SPRB-$21.14

ROE (TTM)

AVXL-1143.0%

SPRB-15540.0%

ROA (TTM)

AVXL-1072.0%

SPRB-10167.0%

ROIC (TTM)

AVXL-1143.0%

SPRB-14349.0%

Cash

AVXL$118M

SPRB$96M

Debt

AVXL$0

SPRB$7M

Net Cash/Debt

AVXL$118M

SPRB$89M

Current Ratio (TTM)

AVXL15.62x

SPRB9.23x

Quick Ratio (TTM)

AVXL15.51x

SPRB8.81x

Debt/Equity (TTM)

AVXL0.00x

SPRB0.08x

Debt/Assets (TTM)

AVXL0.0%

SPRB0.0%

Interest Coverage (TTM)

AVXLN/A

SPRBN/A

Net Debt/EBITDA (TTM)

AVXL0.00x

SPRB0.00x

Beta

AVXL1.20

SPRB3.63

52W Performance

AVXL-84.9%

SPRB-72.5%

YTD Performance

AVXL-59.5%

SPRB-51.4%

% from 52W High

AVXL-85.0%

SPRB-77.9%

% from 52W Low

AVXL3.5%

SPRB9.2%

Asset Turnover (TTM)

AVXL0.00x

SPRB0.07x

FCF Yield (TTM)

AVXL-21.2%

SPRB-35.3%

Earnings Yield (TTM)

AVXL-9.4%

SPRB-42.4%

Dividend Yield (TTM)

AVXLN/A

SPRBN/A

Rule of 40

AVXL0.0

SPRB0.0

EV/GP/RG

AVXLN/A

SPRBN/A

Ticker research

View AVXL research View SPRB research

Metric	AVXL Anavex Life Sciences Corp	SPRB Spruce Biosciences, Inc
Market & Valuation
Market Cap	$138M	$121M
Enterprise Value	$20M	$32M
Price	$1.49	$44.05
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	26.75x
EV/Sales	0.00x	8.59x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-0.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	377.5%	-75.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-13M	$-51M
FCF (TTM)	$-29M	$-43M
EPS (TTM)	-$0.14	-$21.14
ROE (TTM)	-1143.0%	-15540.0%
ROA (TTM)	-1072.0%	-10167.0%
ROIC (TTM)	-1143.0%	-14349.0%
Financial Health
Cash	$118M	$96M
Debt	$0	$7M
Net Cash/Debt	$118M	$89M
Current Ratio (TTM)	15.62x	9.23x
Quick Ratio (TTM)	15.51x	8.81x
Debt/Equity (TTM)	0.00x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	3.63
52W Performance	-84.9%	-72.5%
YTD Performance	-59.5%	-51.4%
% from 52W High	-85.0%	-77.9%
% from 52W Low	3.5%	9.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	-21.2%	-35.3%
Earnings Yield (TTM)	-9.4%	-42.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AVXL research	View SPRB research